{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:11:03Z","timestamp":1791447063408,"version":"4.3.3"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0207947","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T19:50:43Z","timestamp":1543261843000},"page":"e0207947","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":74,"title":["Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly \u2013 A meta-analysis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6667-6263","authenticated-orcid":true,"given":"Margit","family":"Solym\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Ivic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"P\u00f3t\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-0571","authenticated-orcid":true,"given":"Andr\u00e1s","family":"Garami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4746-9792","authenticated-orcid":true,"given":"Petra","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"P\u00e9terv\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Czopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alizadeh","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Gy\u00f6ngyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Sarl\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"M\u00e1trai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"B\u00e9rczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Balask\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.amjmed.2017.04.004","article-title":"Pharmacologic management of type 2 diabetes mellitus: available therapies","volume":"130","author":"J Thrasher","year":"2017","journal-title":"The American journal of medicine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc16-S013","article-title":"10. Older adults","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"ref3","first-page":"S3","article-title":"Summary of revisions to the 2011 clinical practice recommendations","volume":"34","author":"A American Diabetes","year":"2011","journal-title":"Diabetes Care"},{"key":"ref4","first-page":"E31","article-title":"Drug-induced weight gain","volume":"9","author":"R Ness-Abramof","year":"2005","journal-title":"Timely Top Med Cardiovasc Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.ijo.0803695","article-title":"Metformin and body weight","volume":"32","author":"A Golay","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/meta.2001.24192","article-title":"Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30","volume":"50","author":"C Glueck","year":"2001","journal-title":"Metabolism-Clinical and Experimental"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1463-1326.2008.00857.x","article-title":"Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?","volume":"10","author":"I Kusaka","year":"2008","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2337\/diacare.24.3.489","article-title":"Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects","volume":"24","author":"E Mannucci","year":"2001","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MED.0000000000000095","article-title":"Effects of metformin on weight loss: potential mechanisms","volume":"21","author":"SK Malin","year":"2014","journal-title":"Current Opinion in Endocrinology, Diabetes and Obesity"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.4161\/cc.26928","article-title":"Metformin: do we finally have an anti-aging drug?","volume":"12","author":"VN Anisimov","year":"2013","journal-title":"Cell Cycle"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.4161\/cc.7.17.6625","article-title":"Metformin slows down aging and extends life span of female SHR mice","volume":"7","author":"VN Anisimov","year":"2008","journal-title":"Cell Cycle"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012","volume":"314","author":"A Menke","year":"2015","journal-title":"Jama"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"342650","DOI":"10.1155\/2013\/342650","article-title":"A growing troubling triad: diabetes, aging, and falls","volume":"2013","author":"RT Crews","year":"2013","journal-title":"J Aging Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1046\/j.1532-5415.2003.51558.x","article-title":"Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women","volume":"51","author":"KE Ensrud","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ajcn\/66.4.760","article-title":"Anorexia of aging: physiologic and pathologic","volume":"66","author":"JE Morley","year":"1997","journal-title":"The American journal of clinical nutrition"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/jgs.14064","article-title":"Involuntary Weight Loss Secondary to Metformin Use in Elderly Adults","volume":"64","author":"O P\u00e9rez\u2010Hern\u00e1ndez","year":"2016","journal-title":"Journal of the American Geriatrics Society"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"ER Hajjar","year":"2007","journal-title":"The American journal of geriatric pharmacotherapy"},{"key":"ref18"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS medicine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Controlled clinical trials"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"Bmj"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/9780470712184.ch8","article-title":"Assessing risk of bias in included studies","author":"J Higgins","year":"2008","journal-title":"Cochrane handbook for systematic reviews of interventions: Cochrane book series"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/gerona\/61.10.1075","article-title":"The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes","volume":"61","author":"J Crandall","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diacare.17.10.1100","article-title":"Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations: a double-blind controlled study","volume":"17","author":"LS Hermann","year":"1994","journal-title":"Diabetes care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/archinternmed.2009.20","article-title":"Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus","volume":"169","author":"A Kooy","year":"2009","journal-title":"Archives of internal medicine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e008376","DOI":"10.1136\/bmjopen-2015-008376","article-title":"Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus\u2014the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial","volume":"6","author":"L Lundby-Christensen","year":"2016","journal-title":"BMJ open"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diacare.21.5.701","article-title":"The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control","volume":"21","author":"AC Robinson","year":"1998","journal-title":"Diabetes Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2337\/diacare.25.12.2133","article-title":"Combination of insulin and metformin in the treatment of type 2 diabetes","volume":"25","author":"MG Wulffel\u00e9","year":"2002","journal-title":"Diabetes care"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1464-5491.1990.tb01433.x","article-title":"Comparison of tolbutamide and metformin in elderly diabetic patients","volume":"7","author":"S Josephkutty","year":"1990","journal-title":"Diabet Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1463-1326.2009.01051.x","article-title":"Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24\u2010week, double\u2010blind, randomized trial","volume":"11","author":"A Schweizer","year":"2009","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"NJ Stone","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacl.2015.11.010","article-title":"A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality","volume":"10","author":"RK Wadhera","year":"2016","journal-title":"Journal of clinical lipidology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins AI and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"104","author":"AR Sharrett","year":"2001","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e91111","DOI":"10.1371\/journal.pone.0091111","article-title":"Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity","volume":"9","author":"L Woo S-","year":"2014","journal-title":"PloS one"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2012.01.028","article-title":"The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats","volume":"1444","author":"W-s Lv","year":"2012","journal-title":"Brain research"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/eje.0.1490421","article-title":"Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men","volume":"149","author":"P Boudou","year":"2003","journal-title":"European Journal of Endocrinology"},{"key":"ref37","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"P Moghetti","year":"2000","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2012.02.109","article-title":"Possible involvement of melanocortin-4-receptor and AMP-activated protein kinase in the interaction of glucagon-like peptide-1 and leptin on feeding in rats","volume":"420","author":"E Poleni P-","year":"2012","journal-title":"Biochemical and biophysical research communications"},{"key":"ref39","first-page":"336","article-title":"Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes","volume":"17","author":"E Mannucci","year":"2004","journal-title":"Diabetes, nutrition & metabolism"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0207947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:45:28Z","timestamp":1589031928000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0207947"}},"subtitle":[],"editor":[{"given":"Clemens","family":"F\u00fcrnsinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0207947","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]}}}